Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 53, Issue 1, Pages 281-286Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00441-08
Keywords
-
Categories
Funding
- Salix Pharmaceuticals, Inc., Morrisville, NC
Ask authors/readers for more resources
Rifaximin, ampicillin-sulbactam, neomycin, nitazoxanide, teicoplanin, and vancomycin were tested against 536 strains of anaerobic bacteria. The overall MIC of rifaximin at which 50% of strains were inhibited was 0.25 mu g/ml. Ninety percent of the strains tested were inhibited by 256 mu g/ml of rifaximin or less, an activity equivalent to those of teicoplanin and vancomycin but less than those of nitazoxanide and ampicillin-sulbactam.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available